Antimicrobial light-based interventions for management of oral infections: a mini review.
4 affiliations
- 1Department of Dentistry, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre, Brazil, Porto Alegre, Brazil.
- 2Department of Preventive and Restorative Sciences, Dental School, University of Pennsylvania-UPENN, Philadelphia, PA, United States.
- 3Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
- 4Department of Morphological Sciences, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre, Brazil.
Abstract
Limitations of conventional disinfectants and rising antimicrobial resistance have accelerated the development of light-based, resistance-free interventions. This mini-review describes the mechanisms and evidence for antimicrobial photodynamic therapy (aPDT), antimicrobial blue light (aBL), antimicrobial selective photothermolysis (aSP) and photothermal therapy (PTT). Unlike antibiotics, light-based interventions avoid inducing microbial resistance or disturbing the host microflora. Interventions were evaluated across endodontics, periodontal and peri-implant disease, oral mucosal infections, and dental caries. Current literature is heavily skewed towards aPDT, leaving other interventions underexplored despite their mechanistic promise. aPDT is currently the only one with systematic reviews and meta-analyses, whereas evidence for aBL and PTT remains confined to in-vitro and preclinical studies. In periodontitis, aPDT achieved statistical significance, but clinical improvements were negligible and below meaningful thresholds, leading official guidelines from major bodies against its routine use. Clinical evidence currently supports aPDT only in oral candidiasis, where outcomes matched conventional treatments. aSP, tested only as pulsed Nd:YAG or CW diode adjuncts to debridement, was not superior to conventional methods, and selectivity has never been measured clinically. Promising directions are aBL, due to its selectivity for periodontopathogens and link to autofluorescence-based diagnosis, and PTT for its combined antimicrobial and regeneration capacity. Physical limiting factors for aPDT and aBL are shallow effective depth and oxygen dependence in anaerobic niches, and a narrow thermal safety margin for aSP and PTT. A recurring gap is lack of translation between microbial reduction and improved clinical outcomes across interventions, highlighting the need for multi-center trials based on clinically proven standardized protocols.
Related
- Clinical research advances in pulmonary infections in 2025: a narrative review of multipathogen assessment, precision diagnosis, and integrated management
- Digital, Mobile and Artificial Intelligence‐Supported Interventions for Pressure Injury Prevention and Management: A Systematic Review of Clinical, Workflow and Implementation Outcomes
- Home-based non-pharmacological interventions for cognition and diabetes self-management in adults with type 2 diabetes: a systematic review
- Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials
- Adjunctive Strategies to Enhance Antimicrobial Photodynamic Therapy in Oral Infections: A Systematic Review of Randomized Controlled Trials
BibTeX
@article{hiltch2026antimicrobial,
title = {{Antimicrobial light-based interventions for management of oral infections: a mini review.}},
author = {Gal Hiltch and Liviu Steier and Katia Rupel and Giulia Ottaviani and José Antonio Poli De Figueiredo},
journal = {Frontiers in oral health},
year = {2026},
month = oct,
doi = {10.3389/froh.2026.1981642},
url = {https://europepmc.org/article/MED/42953128},
note = {CC BY},
}
RIS
TY - JOUR
TI - Antimicrobial light-based interventions for management of oral infections: a mini review.
AU - Gal Hiltch
AU - Liviu Steier
AU - Katia Rupel
AU - Giulia Ottaviani
AU - José Antonio Poli De Figueiredo
PY - 2026
DA - 2026/10/14
JO - Frontiers in oral health
DO - 10.3389/froh.2026.1981642
UR - https://europepmc.org/article/MED/42953128
AB - Limitations of conventional disinfectants and rising antimicrobial resistance have accelerated the development of light-based, resistance-free interventions. This mini-review describes the mechanisms and evidence for antimicrobial photodynamic therapy (aPDT), antimicrobial blue light (aBL), antimicrobial selective photothermolysis (aSP) and photothermal therapy (PTT). Unlike antibiotics, light-based interventions avoid inducing microbial resistance or disturbing the host microflora. Interventions were evaluated across endodontics, periodontal and peri-implant disease, oral mucosal infections, and dental caries. Current literature is heavily skewed towards aPDT, leaving other interventions underexplored despite their mechanistic promise. aPDT is currently the only one with systematic reviews and meta-analyses, whereas evidence for aBL and PTT remains confined to in-vitro and preclinical studies. In periodontitis, aPDT achieved statistical significance, but clinical improvements were negligible and below meaningful thresholds, leading official guidelines from major bodies against its routine use. Clinical evidence currently supports aPDT only in oral candidiasis, where outcomes matched conventional treatments. aSP, tested only as pulsed Nd:YAG or CW diode adjuncts to debridement, was not superior to conventional methods, and selectivity has never been measured clinically. Promising directions are aBL, due to its selectivity for periodontopathogens and link to autofluorescence-based diagnosis, and PTT for its combined antimicrobial and regeneration capacity. Physical limiting factors for aPDT and aBL are shallow effective depth and oxygen dependence in anaerobic niches, and a narrow thermal safety margin for aSP and PTT. A recurring gap is lack of translation between microbial reduction and improved clinical outcomes across interventions, highlighting the need for multi-center trials based on clinically proven standardized protocols.
SN - 2673-4842
ER -